The Amityville-based pharmaceuticals company Hi-Tech Pharmacal Co. Inc. has hired a new chief scientific officer.
The executive, Kamel Egbaria, has a doctorate in pharmaceutics from Hebrew University in Jerusalem, Israel, and has more than 25 years experience in pharmaceutical management and research, the company said.
Egbaria joined Hi-Tech Pharmacal from Qualitest Pharmaceuticals, of Huntsville, Ala., where he was chief scientific officer and vice president of research and development. During his six years with Qualitest Pharmaceuticals he was responsible for research and development and regulatory affairs.
David Seltzer, president and chief executive of Hi-Tech Pharmacal, said, “We welcome Kamel to our management team and believe that his experience will help Hi-Tech Pharmacal grow and achieve continued success.”
Read more of Inside Long Island Business